RAC 5.76% $1.64 race oncology ltd

Industry news, page-1713

  1. 2,667 Posts.
    lightbulb Created with Sketch. 2405
    It's a good thing because it creates a bad look in the market, but in this instance the new chair is far better placed to lead the business to the outcomes they're seeking, and I suspect he's off the Board because some people say he's a lazy WOFTAM. (A little like things got much better at RAC when the previous Chair was replaced and the organisation refocussed on shareholder value.)
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.